Sangram Nag

Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-l-deprenyl using whole hemisphere autoradiography

Balázs Gulyás, Elena Pavlova, P. Kása et al. · Neurochemistry International · 2010 · 197 citations

Whole Hemisphere Autoradiography, Alzheimer's Disease, Dementia +10

Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains

Laëtitia Lemoine, Per-Göran Gillberg, Marie Svedberg et al. · Alzheimer s Research & Therapy · 2017 · 106 citations · Full text

All‐cause and cardiovascular mortality in diabetic subjects increases significantly with reduced estimated glomerular filtration rate (eGFR): 10 years’ data from the South Tees Diabetes Mortality study

Sangram Nag, Rudy Bilous, William F. Kelly et al. · Diabetic Medicine · 2007 · 83 citations

In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer’s disease patients

Andrea Varrone, Patrik Mattsson, Anton Forsberg et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 82 citations

Positron Emission Tomography, Neuroimaging Biomarkers, Neurodegenerative Diseases +12

In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, ¹⁸F-Labeled Deuterated Fluorodeprenyl

Sangram Nag, Patrik Fazio, Lutz Lehmann et al. · Journal of Nuclear Medicine · 2015 · 82 citations · Full text